Industries > Pharma > Veterinary Therapeutics Market Report 2021-2031
Veterinary Therapeutics Market Report 2021-2031
By Product Type (Drugs, Vaccines, and Medicated Feed Additives), By Animal (Companion Animal, and Livestock Animal), By Route of Administration (Oral, Parenteral, and Topical), By End User (Veterinary Hospital, Veterinary Specialty Clinics, Research Institutes and Universities, and Others), By Distribution Channel (Retail Pharmacies, Veterinary Hospital Pharmacies, and Online Pharmacies), and Leading Regional/Country market analysis
Veterinary Therapeutics Market– our new study reveals trends, R&D progress, and predicted revenues
Where the Veterinary Therapeutics is market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our 250+ page report provides 370+ tables and 350+ charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Veterinary Therapeutics Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
• Revenue and growth forecasts from 2021 to 2031 for the Global Veterinary Therapeutics Market By Product Type
• Drugs
o Anti-infective
o Anti-inflammatory
o Parasiticides
o Others
• Vaccines
o Inactivated Vaccines
o Live Attenuated Vaccines
o Recombinant Vaccines
o Others
• Medicated Feed Additives
o Antibiotics
o Amino Acids
o Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Veterinary Therapeutics Market By Animal
• Companion Animal
• Livestock Animal
• Revenue and growth forecasts from 2021 to 2031 for the Global Veterinary Therapeutics Market By Route of Administration
• Oral
• Parenteral
• Topical
• Revenue and growth forecasts from 2021 to 2031 for the Global Veterinary Therapeutics Market By End User
• Veterinary Hospital
• Veterinary Specialty Clinics
• Research Institutes and Universities
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Veterinary Therapeutics Market By Distribution Channel
• Retail Pharmacies
• Veterinary Hospital Pharmacies
• Online Pharmacies
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Veterinary Therapeutics Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Veterinary Therapeutics Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Veterinary Therapeutics Market report helps you
In summary, our 250+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Veterinary Therapeutics Market, with forecasts for Get our report today Veterinary Therapeutics Market Forecast 2021-2031: By Product, Animal, Route of Administration, End User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Veterinary Therapeutics market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Veterinary Therapeutics Market. Some of the company’s profiled in this report include
• Zoetis, Inc.
• Merck Animal Health
• Elanco Animal Health
• Boehringer Ingelheim GmbH
• Ceva Santé Animale
• Virbac
• Vetoquinol S.A.
• Dechra Pharmaceuticals PLC
• Biovac
• The Chanelle Group
• ImmuCell Corporation.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Veterinary Therapeutics Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Veterinary Therapeutics Market Report 2021-2031: By Product Type (Drugs, Vaccines, and Medicated Feed Additives), By Animal (Companion Animal, and Livestock Animal), By Route of Administration (Oral, Parenteral, and Topical), By End User (Veterinary Hospital, Veterinary Specialty Clinics, Research Institutes and Universities, and Others), By Distribution Channel (Retail Pharmacies, Veterinary Hospital Pharmacies, and Online Pharmacies), and Leading Regional/Country market analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Veterinary Therapeutics Market
2.1. Veterinary Therapeutics Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Veterinary Therapeutics Market Overview
3.1. Global Veterinary Therapeutics Market Size and Forecast By Region
3.2. Global Veterinary Therapeutics Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Growth in the Companion Animal Population
3.3.1.2. Increase usage of Veterinary Therapeutics for Zoonotic Diseases
3.3.1.3. Increasing awareness regarding Zoonotic Diseases
3.3.1.4. Increasing disposable income
3.3.2. Market Restraints
3.3.2.1. Stringent Regulation
3.3.2.2. High Cost of product
3.3.3. Opportunities
3.3.3.1. Increasing initiative and awareness program
3.3.3.2. Increasing Advanced therapeutics for development of new vaccines for an array of diseases
3.3.4. Challenges
3.3.4.1. Side effects associated with the therapeutics
3.3.4.2. Low treatment rate
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Veterinary Therapeutics Market Analysis and Forecast 2021-2031, By Product Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Drugs
4.1.1.1. Drugs market size and forecast, 2021-2031 (USD Million)
4.1.2. Vaccines
4.1.2.1. Vaccines market size and forecast, 2021-2031 (USD Million)
4.1.3. Medicated Feed Additives
4.1.3.1. Medicated Feed Additives market size and forecast, 2021-2031 (USD Million)
5. Global Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 By Animal (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Companion Animal
5.1.1.1. Companion Animal market size and forecast, 2021-2031 (USD Million)
5.1.2. Livestock Animal
5.1.2.1. Livestock Animal market size and forecast, 2021-2031 (USD Million)
6. Global Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 By Route of Administration (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Oral
6.1.1.1. Oral market size and forecast, 2021-2031 (USD Million)
6.1.2. Parenteral
6.1.2.1. Parenteral market size and forecast, 2021-2031 (USD Million)
6.1.3. Topical
6.1.3.1. Topical market size and forecast, 2021-2031 (USD Million)
7. Global Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Veterinary Hospital
7.1.1.1. Veterinary Hospital market size and forecast, 2021-2031 (USD Million)
7.1.2. Research Institutes and Universities
7.1.2.1. Research Institutes and Universities market size and forecast, 2021-2031 (USD Million)
7.1.3. Veterinary Specialty Clinics
7.1.3.1. Veterinary Specialty Clinics market size and forecast, 2021-2031 (USD Million)
7.1.4. Others
7.1.4.1. Others Market size and forecast, 2021-2031 (USD Million)
8. Global Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Veterinary Hospital Pharmacy
8.1.1.1. Veterinary Hospital Pharmacy market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Pharmacy
8.1.2.1. Retail Pharmacy market size and forecast, 2021-2031 (USD Million)
8.1.3. Online Pharmacies
8.1.3.1. Online Pharmacies market size and forecast, 2021-2031 (USD Million)
9. North America Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Veterinary Therapeutics Market Size and Forecast By Product Type
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Veterinary Therapeutics Market Size and Forecast By Animal
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Veterinary Therapeutics Market Size and Forecast By Route of Administration
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Veterinary Therapeutics Market Size and Forecast By End-User
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Veterinary Therapeutics Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Veterinary Therapeutics Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Veterinary Therapeutics Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Veterinary Therapeutics Market Size and Forecast By Product Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Veterinary Therapeutics Market Size and Forecast By Animal
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Veterinary Therapeutics Market Size and Forecast By Patient Demographics
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Veterinary Therapeutics Market Size and Forecast By End-User
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Veterinary Therapeutics Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Veterinary Therapeutics Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Veterinary Therapeutics Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Veterinary Therapeutics Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Veterinary Therapeutics Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Veterinary Therapeutics Market Size and Forecast By Product Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Veterinary Therapeutics Market Size and Forecast By Animal
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Veterinary Therapeutics Market Size and Forecast By Route of Administration
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Veterinary Therapeutics Market Size and Forecast By End-User
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Veterinary Therapeutics Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Veterinary Therapeutics Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Veterinary Therapeutics Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Veterinary Therapeutics Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Veterinary Therapeutics Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Veterinary Therapeutics Market Size and Forecast By Product Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Veterinary Therapeutics Market Size and Forecast By Animal
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Veterinary Therapeutics Market Size and Forecast By Route of Administration
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Veterinary Therapeutics Market Size and Forecast By End-User
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Veterinary Therapeutics Market Size and Forecast By Distribution Channel
12.7. Brazil Veterinary Therapeutics Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Veterinary Therapeutics Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Veterinary Therapeutics Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Veterinary Therapeutics Market Size and Forecast By Product Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Veterinary Therapeutics Market Size and Forecast By Animal
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Veterinary Therapeutics Market Size and Forecast By Route of Administration
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Veterinary Therapeutics Market Size and Forecast By End-User
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Veterinary Therapeutics Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Veterinary Therapeutics Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Veterinary Therapeutics Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Veterinary Therapeutics Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Veterinary Therapeutics Market
14.1. Zoetis, Inc.
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Merck Animal Health
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. Elanco Animal Health
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. BOEHRINGER INGELHEIM GMBH
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. CEVA SANTÉ ANIMALE
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. Virbac
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Vetoquinol S.A.
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. Dechra Pharmaceuticals PLC
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Biovac
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. The Chanelle Group
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Veterinary Therapeutics Market Drivers & Restraints 2021
Table 7. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 44. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 45. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 46. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 47. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 48. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 49. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 50. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 51. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 52. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 53. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 54. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 55. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 56. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 57. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 58. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 59. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 60. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 61. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 62. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 63. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 64. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 65. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 66. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 67. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 68. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 69. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 70. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 71. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 72. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 73. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 74. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 75. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 76. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 77. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 78. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 79. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 80. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 81. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 82. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 83. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 84. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 85. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 86. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 87. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 88. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 89. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 90. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 91. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 92. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 93. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 94. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 95. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 96. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 97. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 98. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 99. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 100. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 101. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 102. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 103. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 104. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 105. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 106. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 107. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 108. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 109. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 110. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 111. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 112. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 113. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 114. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 115. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 116. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 117. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 118. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 119. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 120. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 121. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 122. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 123. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 124. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 125. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 126. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 127. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 128. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 129. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 130. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 131. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 132. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 133. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 134. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 135. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 136. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 137. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 138. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 139. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 140. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 141. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 142. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 143. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 144. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 145. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 146. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 147. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 148. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 149. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 150. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 151. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 152. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 153. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 154. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 155. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 156. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 157. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 158. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 159. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 160. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 161. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 162. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 163. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 164. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 165. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 166. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 167. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 168. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 183. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 184. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 185. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 186. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 187. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 188. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 189. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 190. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 191. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 192. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 193. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 194. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 195. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 196. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 197. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 198. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 199. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 202. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Leading 10 Veterinary Therapeutics Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 352. Zoetis, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 353. Zoetis, Inc. Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 354. Merck Animal HealthProfile 2019 (CEO, HQ, Founded, Website)
Table 355. Merck Animal HealthVeterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 356. Elanco Animal Health Profile 2019 (CEO, HQ, Founded, Website)
Table 357. Elanco Animal Health.Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 358. BOEHRINGER INGELHEIM GMBH Profile 2019 (CEO, HQ, Founded, Website)
Table 359. BOEHRINGER INGELHEIM GMBH Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 360. CEVA SANTÉ ANIMALE Profile 2019 (CEO, HQ, Founded, Website)
Table 361. CEVA SANTÉ ANIMALE Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 362. Virbac Profile 2019 (CEO, HQ, Founded, Website)
Table 363. Virbac Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 364. Vetoquinol S.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 365. Vetoquinol S.A. Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 366. Dechra Pharmaceuticals PLC Profile 2019 (CEO, HQ, Founded, Website)
Table 367. Dechra Pharmaceuticals PLC Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 368. Biovac Profile 2019 (CEO, HQ, Founded, Website)
Table 369. Biovac Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 370. The Chanelle Group Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 371. The Chanelle Group Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 372. Other Companies Involved in the Veterinary Therapeutics Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Veterinary Therapeutics Market Drivers & Restraints 2021
Figure 7. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 44. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 45. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 46. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 47. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 48. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 49. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 50. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 51. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 52. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 53. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 54. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 55. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 56. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 57. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 58. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 59. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 60. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 61. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 62. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 63. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 64. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 65. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 66. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 67. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 68. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 69. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 70. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 71. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 72. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 73. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 74. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 75. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 76. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 77. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 78. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 79. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 80. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 81. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 82. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 83. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 84. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 85. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 86. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 87. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 88. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 89. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 90. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 91. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 92. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 93. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 94. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 95. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 96. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 97. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 98. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 99. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 100. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 101. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 102. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 103. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 104. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 105. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 106. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 107. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 108. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 109. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 110. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 111. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 112. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 113. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 114. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 115. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 116. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 117. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 118. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 119. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 120. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 121. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 122. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 123. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 124. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 125. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 126. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 127. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 128. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 129. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 130. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 131. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 132. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 133. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 134. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 135. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 136. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 137. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 138. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 139. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 140. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 141. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 142. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 143. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 144. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 145. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 146. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 147. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 148. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 149. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 150. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 151. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 152. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 153. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 154. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 155. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 156. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 157. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 158. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 159. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 160. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 161. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 162. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 163. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 164. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 165. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 166. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 167. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 168. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 183. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 184. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 185. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 186. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 187. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 188. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 189. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 190. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 191. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 192. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 193. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 194. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 195. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 196. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 197. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 198. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 199. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 200. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 201. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 202. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 203. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 204. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 205. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 206. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 207. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 208. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 209. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 210. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 211. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 212. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 213. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 214. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 215. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 216. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 217. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 218. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 219. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 220. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 221. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 222. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 223. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 224. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 225. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 226. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 227. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 228. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 229. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 230. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 231. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 232. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Porter’s Five Force Analysis
Companies Mentioned
1. IVF Limited
2. Minitube Group
3. Ovagenix
4. Jorgensen Labs
5. Intervet Inc.
6. PBS Animal Health
7. Swine Genetics International
8. Santa Cruz Biotechnology, Inc.
9. Revival Animal Health
10. IMV TECHNOLOGIES GROUP
11. Zoetis
12. NEOGEN Corporation
13. Biovine Elite, LLC
14. Alta Genetics, Inc.
15. Paragon Veterinary group
16. Stateline Veterinary Services
17. Equine Fertility Center
18. TransOva Genetics
19. Trivector Biomed LLP
20. Planer
21. Boehringer Ingelheim
22. Zoetis
23. Elanco
24. Merck Animal Health
25. Bayer
26. Norbrook Laboratories
27. Ceva Sant Animale
28. Dechra Pharmaceuticals
29. Chanelle
30. K-Laser USA
31. Assisi Animal Health
32. Merck & Co.
33. Merial
34. Virbac S.A.
35. IDEXX Laboratories
36. Vetoquinol S.A.
37. Evonik
38. DuPont
39. DSM
40. Adisseo
41. BASF
42. ADM
43. Nutreco
44. Novusint
45. Cargill
46. Charoen Pokphand Group
47. Sumitomo Chemical
48. Kemin Industries
49. Biomin, Alltech
50. Addcon, Bio Agri Mix
51. Boston Scientific
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Veterinary Therapeutics Market
2.1. Veterinary Therapeutics Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Veterinary Therapeutics Market Overview
3.1. Global Veterinary Therapeutics Market Size and Forecast By Region
3.2. Global Veterinary Therapeutics Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Growth in the Companion Animal Population
3.3.1.2. Increase usage of Veterinary Therapeutics for Zoonotic Diseases
3.3.1.3. Increasing awareness regarding Zoonotic Diseases
3.3.1.4. Increasing disposable income
3.3.2. Market Restraints
3.3.2.1. Stringent Regulation
3.3.2.2. High Cost of product
3.3.3. Opportunities
3.3.3.1. Increasing initiative and awareness program
3.3.3.2. Increasing Advanced therapeutics for development of new vaccines for an array of diseases
3.3.4. Challenges
3.3.4.1. Side effects associated with the therapeutics
3.3.4.2. Low treatment rate
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Veterinary Therapeutics Market Analysis and Forecast 2021-2031, By Product Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Drugs
4.1.1.1. Drugs market size and forecast, 2021-2031 (USD Million)
4.1.2. Vaccines
4.1.2.1. Vaccines market size and forecast, 2021-2031 (USD Million)
4.1.3. Medicated Feed Additives
4.1.3.1. Medicated Feed Additives market size and forecast, 2021-2031 (USD Million)
5. Global Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 By Animal (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Companion Animal
5.1.1.1. Companion Animal market size and forecast, 2021-2031 (USD Million)
5.1.2. Livestock Animal
5.1.2.1. Livestock Animal market size and forecast, 2021-2031 (USD Million)
6. Global Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 By Route of Administration (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Oral
6.1.1.1. Oral market size and forecast, 2021-2031 (USD Million)
6.1.2. Parenteral
6.1.2.1. Parenteral market size and forecast, 2021-2031 (USD Million)
6.1.3. Topical
6.1.3.1. Topical market size and forecast, 2021-2031 (USD Million)
7. Global Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Veterinary Hospital
7.1.1.1. Veterinary Hospital market size and forecast, 2021-2031 (USD Million)
7.1.2. Research Institutes and Universities
7.1.2.1. Research Institutes and Universities market size and forecast, 2021-2031 (USD Million)
7.1.3. Veterinary Specialty Clinics
7.1.3.1. Veterinary Specialty Clinics market size and forecast, 2021-2031 (USD Million)
7.1.4. Others
7.1.4.1. Others Market size and forecast, 2021-2031 (USD Million)
8. Global Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Veterinary Hospital Pharmacy
8.1.1.1. Veterinary Hospital Pharmacy market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Pharmacy
8.1.2.1. Retail Pharmacy market size and forecast, 2021-2031 (USD Million)
8.1.3. Online Pharmacies
8.1.3.1. Online Pharmacies market size and forecast, 2021-2031 (USD Million)
9. North America Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Veterinary Therapeutics Market Size and Forecast By Product Type
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Veterinary Therapeutics Market Size and Forecast By Animal
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Veterinary Therapeutics Market Size and Forecast By Route of Administration
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Veterinary Therapeutics Market Size and Forecast By End-User
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Veterinary Therapeutics Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Veterinary Therapeutics Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Veterinary Therapeutics Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Veterinary Therapeutics Market Size and Forecast By Product Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Veterinary Therapeutics Market Size and Forecast By Animal
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Veterinary Therapeutics Market Size and Forecast By Patient Demographics
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Veterinary Therapeutics Market Size and Forecast By End-User
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Veterinary Therapeutics Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Veterinary Therapeutics Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Veterinary Therapeutics Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Veterinary Therapeutics Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Veterinary Therapeutics Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Veterinary Therapeutics Market Size and Forecast By Product Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Veterinary Therapeutics Market Size and Forecast By Animal
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Veterinary Therapeutics Market Size and Forecast By Route of Administration
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Veterinary Therapeutics Market Size and Forecast By End-User
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Veterinary Therapeutics Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Veterinary Therapeutics Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Veterinary Therapeutics Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Veterinary Therapeutics Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Veterinary Therapeutics Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Veterinary Therapeutics Market Size and Forecast By Product Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Veterinary Therapeutics Market Size and Forecast By Animal
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Veterinary Therapeutics Market Size and Forecast By Route of Administration
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Veterinary Therapeutics Market Size and Forecast By End-User
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Veterinary Therapeutics Market Size and Forecast By Distribution Channel
12.7. Brazil Veterinary Therapeutics Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Veterinary Therapeutics Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Veterinary Therapeutics Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Veterinary Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Veterinary Therapeutics Market Size and Forecast By Product Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Veterinary Therapeutics Market Size and Forecast By Animal
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Veterinary Therapeutics Market Size and Forecast By Route of Administration
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Veterinary Therapeutics Market Size and Forecast By End-User
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Veterinary Therapeutics Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Veterinary Therapeutics Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Veterinary Therapeutics Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Veterinary Therapeutics Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Veterinary Therapeutics Market
14.1. Zoetis, Inc.
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Merck Animal Health
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. Elanco Animal Health
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. BOEHRINGER INGELHEIM GMBH
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. CEVA SANTÉ ANIMALE
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. Virbac
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Vetoquinol S.A.
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. Dechra Pharmaceuticals PLC
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Biovac
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. The Chanelle Group
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Veterinary Therapeutics Market Drivers & Restraints 2021
Table 7. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 44. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 45. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 46. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 47. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 48. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 49. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 50. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 51. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 52. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 53. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 54. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 55. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 56. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 57. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 58. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 59. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 60. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 61. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 62. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 63. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 64. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 65. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 66. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 67. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 68. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 69. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 70. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 71. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 72. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 73. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 74. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 75. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 76. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 77. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 78. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 79. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 80. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 81. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 82. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 83. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 84. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 85. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 86. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 87. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 88. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 89. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 90. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 91. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 92. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 93. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 94. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 95. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 96. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 97. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 98. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 99. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 100. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 101. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 102. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 103. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 104. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 105. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 106. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 107. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 108. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 109. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 110. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 111. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 112. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 113. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 114. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 115. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 116. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 117. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 118. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 119. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 120. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 121. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 122. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 123. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 124. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 125. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 126. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 127. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 128. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 129. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 130. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 131. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 132. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 133. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 134. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 135. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 136. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 137. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 138. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 139. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 140. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 141. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 142. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 143. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 144. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 145. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 146. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 147. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 148. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 149. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 150. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 151. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 152. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 153. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 154. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 155. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 156. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 157. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 158. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 159. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 160. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 161. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 162. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 163. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 164. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 165. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 166. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 167. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 168. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 183. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 184. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 185. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 186. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 187. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 188. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 189. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 190. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 191. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 192. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 193. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 194. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 195. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 196. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 197. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 198. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 199. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 202. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Leading 10 Veterinary Therapeutics Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 352. Zoetis, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 353. Zoetis, Inc. Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 354. Merck Animal HealthProfile 2019 (CEO, HQ, Founded, Website)
Table 355. Merck Animal HealthVeterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 356. Elanco Animal Health Profile 2019 (CEO, HQ, Founded, Website)
Table 357. Elanco Animal Health.Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 358. BOEHRINGER INGELHEIM GMBH Profile 2019 (CEO, HQ, Founded, Website)
Table 359. BOEHRINGER INGELHEIM GMBH Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 360. CEVA SANTÉ ANIMALE Profile 2019 (CEO, HQ, Founded, Website)
Table 361. CEVA SANTÉ ANIMALE Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 362. Virbac Profile 2019 (CEO, HQ, Founded, Website)
Table 363. Virbac Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 364. Vetoquinol S.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 365. Vetoquinol S.A. Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 366. Dechra Pharmaceuticals PLC Profile 2019 (CEO, HQ, Founded, Website)
Table 367. Dechra Pharmaceuticals PLC Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 368. Biovac Profile 2019 (CEO, HQ, Founded, Website)
Table 369. Biovac Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 370. The Chanelle Group Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 371. The Chanelle Group Veterinary Therapeutics Product Offering (Segment, Product Offerings)
Table 372. Other Companies Involved in the Veterinary Therapeutics Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Veterinary Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Veterinary Therapeutics Market Drivers & Restraints 2021
Figure 7. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Vaccines Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Medicated Feed Additives Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Companion Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Livestock Animal Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 44. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 45. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 46. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 47. Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 48. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 49. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 50. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 51. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 52. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 53. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 54. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 55. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 56. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 57. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 58. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 59. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 60. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 61. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 62. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 63. Topical Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 64. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 65. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 66. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 67. Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 68. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 69. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 70. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 71. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 72. Veterinary Hospital Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 73. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 74. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 75. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 76. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 77. Research Institutes and Universities Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 78. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 79. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 80. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 81. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 82. Veterinary Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 83. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 84. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 85. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 86. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 87. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 88. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 89. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 90. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 91. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 92. Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 93. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 94. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 95. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 96. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 97. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 98. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 99. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 100. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 101. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 102. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 103. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 104. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 105. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 106. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 107. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 108. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 109. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 110. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 111. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 112. North America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 113. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 114. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 115. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 116. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 117. North America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 118. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 119. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 120. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 121. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 122. North America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 123. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 124. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 125. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 126. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 127. North America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 128. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 129. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 130. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 131. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 132. North America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 133. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 134. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 135. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 136. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 137. North America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 138. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 139. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 140. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 141. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 142. North America Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 143. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 144. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 145. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 146. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 147. US Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 148. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 149. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 150. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 151. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 152. Canada Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 153. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 154. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 155. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 156. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 157. Europe Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 158. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 159. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 160. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 161. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 162. Europe Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 163. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 164. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 165. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 166. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 167. Europe Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 168. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. Europe Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. Europe Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. Europe Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 183. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 184. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 185. Europe Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 186. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 187. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 188. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 189. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 190. UK Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 191. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 192. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 193. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 194. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 195. Germany Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 196. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 197. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 198. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 199. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 200. France Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 201. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 202. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 203. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 204. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 205. Rest of Europe Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 206. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 207. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 208. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 209. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 210. Asia Pacific Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 211. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 212. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 213. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 214. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 215. Asia Pacific Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 216. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 217. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 218. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 219. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 220. Asia Pacific Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 221. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 222. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 223. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 224. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 225. Asia Pacific Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 226. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 227. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 228. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 229. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 230. Asia Pacific Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 231. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 232. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Asia Pacific Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. Asia Pacific Veterinary Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. China Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. India Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Japan Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. RoAPAC Veterinary Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Middle East Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. Middle East Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. Middle East Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. Middle East Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Middle East Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. Middle East Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. Latin America Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Latin America Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Latin America Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. Latin America Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Latin America Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Latin America Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Africa Veterinary Therapeutics Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Africa Veterinary Therapeutics Market Forecast By Animal 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Africa Veterinary Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Africa Veterinary Therapeutics Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Africa Veterinary Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Africa Veterinary Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Porter’s Five Force Analysis
Companies Mentioned
1. IVF Limited
2. Minitube Group
3. Ovagenix
4. Jorgensen Labs
5. Intervet Inc.
6. PBS Animal Health
7. Swine Genetics International
8. Santa Cruz Biotechnology, Inc.
9. Revival Animal Health
10. IMV TECHNOLOGIES GROUP
11. Zoetis
12. NEOGEN Corporation
13. Biovine Elite, LLC
14. Alta Genetics, Inc.
15. Paragon Veterinary group
16. Stateline Veterinary Services
17. Equine Fertility Center
18. TransOva Genetics
19. Trivector Biomed LLP
20. Planer
21. Boehringer Ingelheim
22. Zoetis
23. Elanco
24. Merck Animal Health
25. Bayer
26. Norbrook Laboratories
27. Ceva Sant Animale
28. Dechra Pharmaceuticals
29. Chanelle
30. K-Laser USA
31. Assisi Animal Health
32. Merck & Co.
33. Merial
34. Virbac S.A.
35. IDEXX Laboratories
36. Vetoquinol S.A.
37. Evonik
38. DuPont
39. DSM
40. Adisseo
41. BASF
42. ADM
43. Nutreco
44. Novusint
45. Cargill
46. Charoen Pokphand Group
47. Sumitomo Chemical
48. Kemin Industries
49. Biomin, Alltech
50. Addcon, Bio Agri Mix
51. Boston Scientific
Companies Profiled in the Report
1. Zoetis, Inc.
2. Merck Animal Health
3. Elanco Animal Health
4. Boehringer Ingelheim GmbH
5. Ceva Santé Animale
6. Virbac
7. Vetoquinol S.A.
8. Dechra Pharmaceuticals PLC
9. Biovac
10. The Chanelle Group
11. ImmuCell Corporation
List of Companies Mentioned in the Report:
1. IVF Limited
2. Minitube Group
3. Ovagenix
4. Jorgensen Labs
5. Intervet Inc.
6. PBS Animal Health
7. Swine Genetics International
8. Santa Cruz Biotechnology, Inc.
9. Revival Animal Health
10. IMV TECHNOLOGIES GROUP
11. Zoetis
12. NEOGEN Corporation
13. Biovine Elite, LLC
14. Alta Genetics, Inc.
15. Paragon Veterinary group
16. Stateline Veterinary Services
17. Equine Fertility Center
18. TransOva Genetics
19. Trivector Biomed LLP
20. Planer
21. Boehringer Ingelheim
22. Zoetis
23. Elanco
24. Merck Animal Health
25. Bayer
26. Norbrook Laboratories
27. Ceva Sant Animale
28. Dechra Pharmaceuticals
29. Chanelle
30. K-Laser USA
31. Assisi Animal Health
32. Merck & Co.
33. Merial
34. Virbac S.A.
35. IDEXX Laboratories
36. Vetoquinol S.A.
37. Evonik
38. DuPont
39. DSM
40. Adisseo
41. BASF
42. ADM
43. Nutreco
44. Novusint
45. Cargill
46. Charoen Pokphand Group
47. Sumitomo Chemical
48. Kemin Industries
49. Biomin, Alltech
50. Addcon, Bio Agri Mix
51. Boston Scientific
List of Organizations Mentioned in the Report:
1. American Veterinary Medical Association
2. World Veterinary Association
3. Student American Veterinary Medical Association
4. American Association of Bovine Practitioners
5. British Veterinary Association
6. Organisation for Economic Co-operation and Development (OECD)
7. European Medicines Agency (EMA)
8. Food and Drug Administration (FDA)
9. National Institutes of Health (NIH)
10. United Nations (UN)
1. Zoetis, Inc.
2. Merck Animal Health
3. Elanco Animal Health
4. Boehringer Ingelheim GmbH
5. Ceva Santé Animale
6. Virbac
7. Vetoquinol S.A.
8. Dechra Pharmaceuticals PLC
9. Biovac
10. The Chanelle Group
11. ImmuCell Corporation
List of Companies Mentioned in the Report:
1. IVF Limited
2. Minitube Group
3. Ovagenix
4. Jorgensen Labs
5. Intervet Inc.
6. PBS Animal Health
7. Swine Genetics International
8. Santa Cruz Biotechnology, Inc.
9. Revival Animal Health
10. IMV TECHNOLOGIES GROUP
11. Zoetis
12. NEOGEN Corporation
13. Biovine Elite, LLC
14. Alta Genetics, Inc.
15. Paragon Veterinary group
16. Stateline Veterinary Services
17. Equine Fertility Center
18. TransOva Genetics
19. Trivector Biomed LLP
20. Planer
21. Boehringer Ingelheim
22. Zoetis
23. Elanco
24. Merck Animal Health
25. Bayer
26. Norbrook Laboratories
27. Ceva Sant Animale
28. Dechra Pharmaceuticals
29. Chanelle
30. K-Laser USA
31. Assisi Animal Health
32. Merck & Co.
33. Merial
34. Virbac S.A.
35. IDEXX Laboratories
36. Vetoquinol S.A.
37. Evonik
38. DuPont
39. DSM
40. Adisseo
41. BASF
42. ADM
43. Nutreco
44. Novusint
45. Cargill
46. Charoen Pokphand Group
47. Sumitomo Chemical
48. Kemin Industries
49. Biomin, Alltech
50. Addcon, Bio Agri Mix
51. Boston Scientific
List of Organizations Mentioned in the Report:
1. American Veterinary Medical Association
2. World Veterinary Association
3. Student American Veterinary Medical Association
4. American Association of Bovine Practitioners
5. British Veterinary Association
6. Organisation for Economic Co-operation and Development (OECD)
7. European Medicines Agency (EMA)
8. Food and Drug Administration (FDA)
9. National Institutes of Health (NIH)
10. United Nations (UN)
Download sample pages
Complete the form below to download your free sample pages for Veterinary Therapeutics Market Report 2021-2031Related reports
Inactivated Vaccines Market Report 2020-2030
Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine...
Full DetailsPublished: 13 May 2021Adult Vaccines Market Report to 2031
The adult vaccines market is expected to attain a significant growth rate due to the increasing incidence of infectious viruses...Full DetailsPublished: 01 January 1970Animal Vaccine Market Report to 2031
Where is the Animal Vaccines market heading? If you are involved in this sector you must read this newly updated...Full DetailsPublished: 01 January 1970Meningococcal Vaccines Market Report 2021-2031
Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is...Full DetailsPublished: 30 September 2021Anti-infective Vaccines Market Report 2021-2031
The rising frequency of bacterial and viral diseases coupled with increased focus on immunisation programmes are two main reasons that...Full DetailsPublished: 01 June 2021Vaccine Delivery Devices Market Report 2021-2031
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product...Full DetailsPublished: 06 January 2021mRNA Vaccines Market Report 2021-2031
The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative...Full DetailsPublished: 01 October 2020Veterinary Vaccines Market Report 2022-2032
The increased frequency of zoonotic illnesses, activities by different government agencies and animal groups to protect animal health, and the...Full DetailsPublished: 28 February 2022Animal Health Market Report 2021-2031
The animal health sector is anticipated to evolve at a rapid pace. The veterinary health industry has diverse opportunities to...Full DetailsPublished: 28 January 2021Veterinary Services Market Report 2021-2031
Where the Veterinary Services market is heading? If you are involved in this industry you must read this newly updated...
Full DetailsPublished: 01 January 1970
Download sample pages
Complete the form below to download your free sample pages for Veterinary Therapeutics Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
27 September 2023
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
25 September 2023
Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
21 September 2023
Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033
The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.
14 September 2023
